webex: https://uwhealth.webex.com/uwhealth/j.php?MTID=m3e0079841c164c924e50bf2b3a66aaaf

Objectives:

  • Summarize the epidemiology and pathogenesis of respiratory syncytial virus (RSV)
  • Evaluate the impact of FDA approval of Beyfortus, Abrysvo, and Arexvy on RSV
  • Provide recommendations to patient and providers for vaccinations and preventative measures
Session date: 
11/28/2023 - 1:00pm to 2:00pm CST
Location: 
In-person and Virtually
Will be determined by room availability
600 Highland Ave
Madison, WI 53705
United States
See map: Google Maps
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 ACPE Contact Hours - Pharmacist Technician
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
Add to calendar: 

Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Natalie Lee, PharmD